Labcorp Clinical Trials is a business segment of Labcorp Inc., a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. Labcorp is a registered trademark and the marketing name for Labcorp Inc. and its subsidiaries around the world.
1 Stay of 3 nights & 1 follow-up visit.
8495-334 A1a
Back To Current Studies1 Stay of 3 nights & 1 follow-up visit.
Study Number
8495-334Group
A1aGender
bothAge
18 - 60Location
Dallas, TexasCompensation
$3,150Study Dates
Mar. 07 - 17, 2023Additional Information
Labcorp Dallas, TX is recruiting for:
- Healthy Adults, age 18-60
- Body Mass Index between 18-32
- Study involves 1 stay of 3 nights, plus 1 follow-up visit
- Compensation up to $3,150 may be provided for time and participation
- Receive up to $250 per qualified participant
Details
The purpose of part A is to evaluate the safety and tolerability (side effects) of the study drug, how much of the study drug and its breakdown products get into the blood stream and urine and how long it takes the body to get rid of them. During your stay, you will be given a single, oral dose of the study drug or placebo (inactive drug) at increasing dose levels.
Depending on the group you are in, you will be dosing in a fasted or fed state.
Call Now to Schedule Your Screening Appointment!
Group A1a:
Check-in: March 7
Check-out: March 10
Follow up Visit: March 17
OR
Group A1b:
Check-in: March 8
Check-out: March 11
Follow up Visit: March 18